𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Azathioprine dose escalation in inflammatory bowel disease

✍ Scribed by C. K. Rayner; A. L. Hart; C. M. M. Hayward; A. V. Emmanuel; M. A. Kamm

Book ID
108603631
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
66 KB
Volume
20
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Azathioprine is effective in corticoster
Azathioprine is effective in corticosteroid-dependent Asian inflammatory bowel disease patients
✍ Kelvin T. Thia; Meiqin Li; Khoon-Lin Ling; San-Choon Kong; Choon-Jin Ooi πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 148 KB

Background: Azathioprine (AZA) is widely used to treat corticosteroid (CS)-dependent IBD patients but evidence supporting its use in Asian IBD patients is limited. We evaluated the efficacy of AZA in a single-center cohort of CS-dependent Asian IBD patients. Methods: Patients treated with AZA were

Increased dosing requirements for 6-merc
Increased dosing requirements for 6-mercaptopurine and azathioprine in inflammatory bowel disease patients six years and younger
✍ Andrew B. Grossman; Angela J. Noble; Petar Mamula; Robert N. Baldassano πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 83 KB

## Background: 6-mercaptopurine (6-mp) and its prodrug azathioprine (aza) are effective for the induction and maintenance of remission and reduction of corticosteroid exposure for pediatric inflammatory bowel disease (ibd). the standard dose of 6-mp is 1.0-1.5 mg/kg/day and for aza is 2.0-2.5 mg/kg